Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Paradoxical Hippocampal Interneurons in a Rat Model of Cortical Dysplasia
Epilepsy/Clinical Neurophysiology (EEG)
P5 - Poster Session 5 (8:00 AM-9:00 AM)
12-005

To investigate the cell type-specific role of hippocampus in a "two-hit" rat model of cortical dysplasia

Cortical dysplasia is one of the most common causes of drug-refractory epilepsy and its treatment remains a clinical challenge. Temporal lobe, apart from the cortex, is frequently identified as the epileptogenic zone in cortical dysplasia patients. As a temporal lobe structure vulnerable to epileptogenesis, the cell type-specific role of hippocampus in cortical dysplasia remains elusive.

In the "two-hit" rat model of cortical dysplasia, structural and functional alteration of hippocampus was studied with immunostaining and electroencephalogram analysis respectively. Density of cells that expressed neuronal nuclei (NeuN), parvalbumin (PV) and somatostatin (SST) in the hippocampus was estimated. Next, their functional roles in seizures were evaluated by optogenetic manipulation. The relationship between cell types were further examined from patch-clamp recordings on the brain slices from cortical dysplasia rats. 

In rats with cortical dysplasia, hippocampus was identified as the seizure onset zone according to time-frequency analysis and high-frequency oscillations. Density of SST-positive neurons were selectively increased in the dentate gyrus of hippocampus. Selective inhibition of SST-positive neurons, paradoxically, can alleviate the seizure severity in vivo and decrease the granule cell excitability ex vivo. Activation of SST-positive neurons, on the other hand, can exacerbate seizures and increase the granule cell excitability.

The paradoxically excitatory SST-positive neurons in the dentate gyrus of hippocampus play a major role in cortical dysplasia-related seizures. Targeting GABAergic neurons as a whole, therefore, may not be a viable therapeutic strategy for cortical dysplasia patients. 

Authors/Disclosures
Yang Zheng, MD, PhD (Dr Yang Zheng)
PRESENTER
Dr. Zheng has nothing to disclose.
No disclosure on file
No disclosure on file
Meiping Ding No disclosure on file